Pierluigi Paracchi, MEc, is co-Founder and Venture Consultant of AurorA-TT, a technology transfer initiative fully focused in the biotech sector, and co-Founder, board member and Strategy Consultant of Altheia Science.

He has more than 15 years of experience as venture capitalist and biotech entrepreneur. He was Founder & CEO of Quantica, the first Italian VC firm exclusively dedicated to research and academic spin-out companies and Venture Consultant at Sofinnova Partners. He was investors and Board Member at EOS – Ethical Oncology Science, acquired by Clovis Oncology for 470M.

He is Co-Founder and CEO of Genenta Science, a cancer gene therapy spin-out from San Raffaele Hospital, the first Italian company listed at NASDAQ in 2021 (NASDAQ: GNTA).  He is Board Member at Assobiotec and Chairman of the SMEs group.

No Comments

Sorry, the comment form is closed at this time.